Announcements
Drinks

14/4/2025 Research EN
Scope proposes an update to its Chemicals Rating Methodology and invites comments
Scope Ratings calls for comments on its Chemicals Rating Methodology by 14 May 2025. The update strengthens, refines and further clarifies the analytical approach. The methodology as proposed might have a positive impact of one notch for one rated entity.

11/4/2025 Research EN
US tariff increases to have uneven direct cashflow, credit impact on European corporates
The protectionist tilt of US trade policy has unsettled investors, partly by clouding the outlook for global growth. But for European companies with US exposure, the impact of higher tariffs on cashflow and credit quality are mixed and case specific.

11/4/2025 Research EN
Austria: higher-than-expected fiscal deficits increase pressure to accelerate structural reforms
Unless Austria’s government undertakes additional reforms to stabilise and reverse rising public debt, public finances will continue to weaken given the modest economic growth outlook and sustained fiscal pressures.

10/4/2025 Research EN
Trade wars likely to weigh on European banks’ asset quality
The sharp correction in European banks’ share prices following the announcement of US tariffs on EU imports reflects mounting investor concerns about the potential implications for asset quality and profitability in a traditionally high-beta sector.

9/4/2025 Research EN
US trade policy: wide-ranging tariff increases heighten global credit risk
The balance of risks for the global credit outlook remains negative. The United States government’s wide-ranging new import tariffs have increased the likelihood of domestic recession and exacerbated global economic and financial vulnerabilities.

7/4/2025 Research EN
Structured Finance Activity Report: ratings drift shifts into positive territory
Scope’s 12-month trailing ratings drift for structured finance transactions moved into positive territory in the first quarter of 2025, with a positive ratio of upgrades over downgrades not seen since 2022.

4/4/2025 Research EN
Scope proposes an update to its Pharmaceutical Companies’ Rating Methodology and invites comments
Scope Ratings calls for comments on its Pharmaceutical Companies’ Rating Methodology by 4 May 2025. The update strengthens, refines and further clarifies Scope’s analytical approach. No impact is expected on out-standing issuer and debt ratings.

4/4/2025 Research EN
UK sovereign rating affirmed, but fiscal pressures intensify; tariffs harm growth
Scope affirmed the UK’s AA ratings on 28 March and kept the Stable Outlook. But fiscal deterioration and weaker debt sustainability increase risks to the rating, while 10% US tariffs on UK exports and 25% on steel and aluminium harm UK growth.

3/4/2025 Research EN
European auto sector: tariff hikes come at difficult time; firms lacking US capacity look exposed
The US’s imposition of 25% tariffs on car imports comes at a bad time for European auto makers which face structural challenges in the shift to electric vehicles, growing competition from Chinese brands, and relatively soft demand in Europe and China.